Brendan Gage works closely with clients in market access, product commercialization, and reimbursements strategy.

He utilizes his experience with health analytics and data to help clients navigate the competitive landscape.

Prior to joining Avalere, Brendan was a research assistant at KNG Health Consulting. In this role, he assisted clients with questions surrounding NTAPs, market access, value-based payment models, and inequities in Medicare populations.

Brendan has a BS in public health from the University of Maryland.

Authored Content


The majority of women are not receiving cervical cancer screenings in compliance with recommendations, with disparities by insurance and age.

Healthcare resource utilization increased for Medicare FFS patients following diagnosis of an ill-defined rare disease.

Variation in mix of payer coverage across autoimmune diseases highlights the need for manufacturers to assess patient payer mix to support channels of access.

Manufacturers impacted by the Part B discarded drug refund policy should assess claims billing and adjudication patterns to inform mitigation strategy.